Chaos, waste and failure: what is wrong with FDA tobacco regulation, and how could it improve?

This is my response to the operational review of the performance of the FDA’s Center for Tobacco Products by the Reagan-Udall foundation. The heart of the problem is the lack of a coherent regulatory strategy, grounded in real-world understanding

Chaos, waste and failure: what is wrong with FDA tobacco regulation, and how could it improve? Read More

A powerful declaration makes a compelling case for tobacco harm reduction

Spain has a vocal and well-funded tobacco control establishment. But the data suggest its traditional approach is failing. 170 national and international experts call for a rethink and make the case that Spain embraces tobacco harm reduction as a real-world public health strategy.

A powerful declaration makes a compelling case for tobacco harm reduction Read More

From FDA to PMI – a sell-out or a bold move for public health?

Matt Holman resigns as Director of the Office of Science at the Center for Tobacco Products at the FDA. He is moving to the tobacco company Philip Morris International to be Vice President of US Scientific Engagement & Regulatory Strategy. What to make of this? I write him an open letter.

From FDA to PMI – a sell-out or a bold move for public health? Read More

Fake news alert: WHO updates its post-truth fact sheet on e-cigarettes

The World Health Organisation continues to present misleading information about e-cigarettes that spreads doubt and confusion among the public, media and policymakers. This post reviews its latest Q & A and finds multiple errors of analysis, misleading statements, and obvious biases.

Fake news alert: WHO updates its post-truth fact sheet on e-cigarettes Read More

Scroll to Top